GE
82
-2
PX
55
2
VRTX
60
-3
CMCSA
46
-2
ROK
48
2
BF.B
50
-3
COST
54
-3
MMC
62
-5
MDT
53
-4
PYPL
47
2
HCP
66
-2
MAR
47
2
CTSH
57
-5
GD
59
-4
CL
59
-2
FIS
51
-2
ISRG
67
-4
BXP
63
-4
EW
16
-9
NWL
35
-5
GE
82
-2
PX
55
2
VRTX
60
-3
CMCSA
46
-2
ROK
48
2
BF.B
50
-3
COST
54
-3
MMC
62
-5
MDT
53
-4
PYPL
47
2
HCP
66
-2
MAR
47
2
CTSH
57
-5
GD
59
-4
CL
59
-2
FIS
51
-2
ISRG
67
-4
BXP
63
-4
EW
16
-9
NWL
35
-5
Financhill
Back

Lvmh Moet Hennessy Louis Vuitton SE Vs. Denali Therapeutics Industry Stock Comparison

Sell
24

LVMUY
Lvmh Moet Hennessy Louis Vuitton SE

Last Price:
133.30
Seasonality Move:
4.11%
Buy
56

DNLI
Denali Therapeutics

Last Price:
30.74
Seasonality Move:
17.79%
Sell
24
Lvmh Moet Hennessy Louis Vuitton SE (LVMUY) is a Sell

Is Lvmh Moet Hennessy Louis Vuitton SE a Buy, Sell or Hold?

  • The current Lvmh Moet Hennessy Louis Vuitton SE [LVMUY] share price is $134.94. The Score for LVMUY is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
  • LVMUY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
56
Denali Therapeutics (DNLI) is a Buy

Is Denali Therapeutics a Buy, Sell or Hold?

  • The current Denali Therapeutics [DNLI] share price is $30.68. The Score for DNLI is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • DNLI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

LVMUY Stock Price Chart

What is Lvmh Moet Hennessy Louis Vuitton SE's stock price today?

  • The Lvmh Moet Hennessy Louis Vuitton SE share price today is $134.94
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LVMUY is experiencing slight selling pressure.

DNLI Stock Price Chart

What is Denali Therapeutics's stock price today?

  • The Denali Therapeutics share price today is $30.68
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DNLI is experiencing slight buying pressure.

LVMUY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.15 Sell
Relative Strength Index (14 RSI): 32.68 Sell
Chaikin Money Flow: -116536 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (136.79 - 149.97) Sell
Bollinger Bands (100): (141.93 - 163.91) Sell

DNLI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.67 Buy
Relative Strength Index (14 RSI): 77.92 Buy
Chaikin Money Flow: 34344 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (23.24 - 27.72) Buy
Bollinger Bands (100): (18.96 - 25.08) Buy

LVMUY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 135.32 Sell
20-day SMA: 143.15 Sell
50-day SMA: 144.05 Sell
200-day SMA: 160.67 Sell
8-day EMA: 136.49 Sell
20-day EMA: 140.06 Sell
50-day EMA: 144.78 Sell
200-day EMA: 156.56 Sell

DNLI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 28 Buy
20-day SMA: 26.04 Buy
50-day SMA: 24.18 Buy
200-day SMA: 20.53 Buy
8-day EMA: 28.54 Buy
20-day EMA: 26.57 Buy
50-day EMA: 24.56 Buy
200-day EMA: 22.12 Buy

Lvmh Moet Hennessy Louis Vuitton SE Earnings Growth & LVMUY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.38 per share, and an increase next year of $0.91 per share.

Denali Therapeutics Earnings Growth & DNLI Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.52 per share, and a decrease next year of $0.07 per share.

Lvmh Moet Hennessy Louis Vuitton SE Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Denali Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):